Barclays’s BrightSpring Health Services BTSG Stock Holding History

Barclays’s Portfolio BTSG Stock Details BTSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.79M	Buy	111,634 +62,949	+129%	+$3.5M	﹤0.01%	1607
2026 Q1	$2.07M	Sell	48,685 -149,801	-75%	-$6.03M	﹤0.01%	2340
2025 Q4	$7.43M	Sell	198,486 -222,978	-53%	-$7.48M	﹤0.01%	1912
2025 Q3	$12.5M	Buy	421,464 +214,111	+103%	+$4.98M	﹤0.01%	1516
2025 Q2	$4.89M	Buy	207,353 +131,353	+173%	+$2.74M	﹤0.01%	2157
2025 Q1	$1.37M	Sell	76,000 -45,251	-37%	-$888K	﹤0.01%	2919
2024 Q4	$2.06M	Sell	121,251 -272,474	-69%	-$4.71M	﹤0.01%	2849
2024 Q3	$5.78M	Buy	393,725 +71,633	+22%	+$898K	﹤0.01%	1967
2024 Q2	$3.66M	Buy	322,092 +30,733	+11%	+$336K	﹤0.01%	1727
2024 Q1	$3.17M	Buy	+291,359	New	+$2.91M	﹤0.01%	2177

Other funds holding BTSG

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's BTSG Position: Q2 2026 in Review

Barclays increased its BrightSpring Health Services (BTSG) stake by 129% in Q2 2026, buying an estimated $3.5M and bringing the position to 111,634 shares worth $7.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1607.

Barclays first reported a position in BTSG in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.5M in Q3 2025. 423 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

Barclays held 111,634 shares of BrightSpring Health Services worth $7.79M as of Q2 2026.
Barclays bought 62,949 BrightSpring Health Services shares in Q2 2026, an estimated $3.5M.
BrightSpring Health Services made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1607 holding.
Barclays first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 10 quarters since.
Barclays's BrightSpring Health Services position peaked at $12.5M in Q3 2025.
423 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.